Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Skin Elements Limited ( (AU:SKN) ).
Skin Elements Limited has released its interim financial report for the half-year ended 31 December 2025, detailing the activities and financial position of the company and its controlled entities. The report formalises key governance and compliance information, including director and auditor details, and maintains the company’s ongoing reporting obligations as an ASX-listed entity, but provides no additional operational or financial performance commentary in the disclosed extract.
The document confirms the company’s registered office, share registry, and audit arrangements, underlining the corporate infrastructure supporting its listed status. While the interim report itself would typically inform stakeholders on performance and strategy, the provided section is largely administrative, offering limited insight into earnings, operations, or strategic developments for the period.
The most recent analyst rating on (AU:SKN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Skin Elements Limited stock, see the AU:SKN Stock Forecast page.
More about Skin Elements Limited
Skin Elements Limited is an Australian-listed company on the ASX under the code SKN. The group operates through controlled entities and is headquartered in West Perth, Western Australia, with a focus on skincare or related products implied by its name and sector classification. Its corporate structure includes a board chaired by CEO Dr Peter Malone and several non-executive directors.
Current Market Cap: A$18M
Find detailed analytics on SKN stock on TipRanks’ Stock Analysis page.